Marine Streptomyces-Derived Natural Products 2024
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Structural Studies on Marine Natural Products".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 1707
Special Issue Editors
Interests: marine natural prodcuts; structure elucidation of natural products; antibacteiral and anti-cancer natural products
Special Issues, Collections and Topics in MDPI journals
Interests: marine actinomycetes; natural products; NMR; structure elucidation; antibiotics; symbiosis; biosynthesis; genomics
Special Issues, Collections and Topics in MDPI journals
Interests: bioactivity natural product; chemistry; chromatography; medicinal and pharmaceutical chemistry; phytochemicals; extraction; antimicrobials; antioxidant activity
Special Issue Information
Dear Colleagues,
It is widely acknowledged that marine microorganisms possess considerable potential as sources of bioactive natural products. Streptomyces, a principal subdivision of Actinobacteria, has been the subject of extensive investigation for its novel secondary metabolites. This fertile microbial genus accounts for over 80% of actinomycete natural products and approximately 50% of all known antibiotics.
Therefore, Streptomyces strains derived from marine-related environments require attention from researchers. More specifically, the most recent advanced approaches demand a thorough examination, such as an isolation strategy for the bioactive metabolites producing Streptomyces strains, applications of the metabolites based on their wide range of bioactivities, and the chemical structure elucidation of marine microbial secondary metabolites. This Special Issue is dedicated to studying the inherent potential of these microorganisms as an abundant reservoir of marine natural products.
Dr. Sang-Jip Nam
Dr. Dong-Chan Oh
Dr. Inho Yang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine streptomyces
- marine natural product
- chemical structure elucidation
- bioactive secondary metabolite
- drug hit/lead discovery
